Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis

Iodinated oestradiol-labeled oestrogen receptor (ER) isoforms devoid of amino-terminal ABC domains represent about two-thirds of the whole receptor population detected in cytosol samples from human breast cancers. This high frequency could not be ascribed to the expression of truncated mRNAs, or to...

Full description

Saved in:
Bibliographic Details
Published inBreast cancer research : BCR Vol. 2; no. 6; pp. 444 - 454
Main Authors Maaroufi, Y, Lacroix, M, Lespagnard, L, Journé, F, Larsimont, D, Leclercq, G
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 01.01.2000
National Library of Medicine - MEDLINE Abstracts
BioMed Central
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Iodinated oestradiol-labeled oestrogen receptor (ER) isoforms devoid of amino-terminal ABC domains represent about two-thirds of the whole receptor population detected in cytosol samples from human breast cancers. This high frequency could not be ascribed to the expression of truncated mRNAs, or to the proteolysis of the native ER peptide at the time of homogenization or assay, suggesting an intracellular proteolysis. Free amino-terminal and ligand-binding domains maintained together within oligomeric structure(s); increase of ionic strength separated them. The amino-terminal region was consistently detected in the cell nucleus by specific immunohistochemistry leading to the concept of a potential intranuclear association between ER cleavage products and/or other regulatory proteins.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1465-5411
1465-542X
1465-542X
DOI:10.1186/bcr92